查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1613338

糖尿病足潰瘍治療市場：治療方法、潰瘍類型和最終用途分類 - 全球預測 2025-2030

Diabetic Foot Ulcer Treatment Market by Treatment (Antibiotic Medications, Biologics, Therapy Devices), Ulcer Type (Ischemic Ulcers, Neuro-Ischemic Ulcers, Neuropathic Ulcers), End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年糖尿病足潰瘍治療市場規模為53.5億美元，預計2024年將達56.9億美元，複合年成長率為6.56%，預計2030年將達83.5億美元。

糖尿病足潰瘍治療市場包括一系列旨在管理和治療糖尿病患者足部潰瘍的產品和服務。這包括先進的創傷護理解決方案，如敷料、移植物和負壓傷口護理，以及藥品，如蛋白酶抑制劑和抗生素治療。由於全世界糖尿病盛行率不斷增加，因此需要這些治療。由於血液循環不良和神經病變，糖尿病會增加足部潰瘍的風險，如果不治療，可能會導致嚴重感染疾病和截肢。應用範圍廣泛，從醫院、診所到居家醫療，最終用途主要針對醫療機構和個人患者。影響成長的關鍵因素包括傷口護理技術的進步、患者對糖尿病併發症嚴重性的認知提高以及政府改善糖尿病護理的努力。機會包括個人化醫療方法以及人工智慧和物聯網的整合以遠端監測和管理潰瘍。建議包括投資生物分解性和生物工程創傷護理產品的研發，並探索技術整合的夥伴關係。然而，市場成長面臨治療成本高和缺乏熟練醫療保健專業人員等挑戰，特別是在低收入地區。監管障礙和報銷問題使市場動態更加複雜。創新機會在於遠端醫療平台的開發，這些平台可以提高患者的依從性，並提供具有成本效益的解決方案，以擴大新興國家的服務範圍。該市場既競爭分散又協作，其特點是不斷的技術進步和主要企業之間的策略聯盟以共用專業知識。注重平衡有效性和可負擔性的以患者為中心的解決方案將推動持續成長，特別是在鼓勵創新和減少市場進入障礙的政策框架的支持下。

主要市場統計
基準年[2023] 53.5億美元
預計年份 [2024] 56.9億美元
預測年份 [2030] 83.5億美元
複合年成長率（%） 6.56%

市場動態：快速發展的糖尿病足潰瘍治療市場的關鍵市場洞察

供需的動態交互作用正在改變糖尿病足潰瘍治療市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 老年族群糖尿病足潰瘍盛行率增加
    • 提高醫療保健專業人員對有效 DPU 管理的認知
  • 市場限制因素
    • 先進傷口護理設備和治療方法高成本
  • 市場機會
    • 繼續積極引進新藥治療糖尿病足潰瘍
    • 擴大開發具有成本效益的糖尿病足潰瘍預防解決方案
  • 市場挑戰
    • 糖尿病足潰瘍的有限報銷政策

波特五力：駕馭糖尿病足潰瘍治療市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解糖尿病足潰瘍治療市場的外部影響

外部宏觀環境因素在塑造糖尿病足潰瘍治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解糖尿病足潰瘍治療市場的競爭格局

對糖尿病足潰瘍治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣糖尿病足潰瘍治療市場供應商的績效評估

FPNV 定位矩陣是評估糖尿病足潰瘍治療市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製糖尿病足潰瘍治療市場的成功之路

對於希望加強在全球市場的影響力的公司來說，對糖尿病足潰瘍治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 老年人糖尿病足潰瘍盛行率增加
      • 醫護人員對有效 DPU 管理的認知正在增強
    • 抑制因素
      • 先進傷口護理設備和治療方法高成本
    • 機會
      • 正在推出治療糖尿病足潰瘍的新治療方法
      • 預防糖尿病足潰瘍的經濟高效解決方案的開發進展
    • 任務
      • 糖尿病足潰瘍的報銷政策有限
  • 市場區隔分析
    • 治療：透過創傷護理敷料和治療設備的創新來最佳化護理並改善患者的治療效果。
    • 最終用途：將低成本、先進的 DFU 治療擴展到全醫院範圍內
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章糖尿病足潰瘍治療市場（依治療）

  • 抗生素
  • 生物製藥
    • 生長因子
    • 植皮
  • 治療設備
    • 負壓傷口治療法
    • 超音波治療
  • 創傷護理敷料
    • 藻酸鹽敷料
    • 膜敷料
    • 泡棉敷料
    • 親水膠體敷料
    • 親水性纖維敷料敷料
    • 水凝膠敷料
    • 手術繃帶

第7章按潰瘍類型分類的糖尿病足潰瘍治療市場

  • 缺血性潰瘍
  • 神經缺血性潰瘍
  • 神經病變潰瘍

第8章糖尿病足潰瘍治療市場：依最終用途分類

  • 門診影像中心
  • 醫院

第9章北美和南美糖尿病足潰瘍治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區糖尿病足潰瘍治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲糖尿病足潰瘍治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 研究人員開發 3D 列印繃帶作為糖尿病足潰瘍的創新治療方法
    • Healthium 推出 Theruptor Novo，一種治療糖尿病足潰瘍的藥物
    • 全錄輝 (Smith-Nephew) 發表的新研究表明，與競爭產品相比，GRAFIX 膜可將糖尿病足潰瘍復發率降低一半。
    • Alkem Laboratories 宣布推出糖尿病足潰瘍管理技術
  • 戰略分析和建議

公司名單

  • 3M Company
  • Adocia SA
  • Alkem Laboratories Ltd.
  • B. Braun SE
  • Cardinal Health, Inc.
  • Centaur Pharmaceuticals Private Limited
  • Cipla Limited
  • Coloplast Corp.
  • ConvaTec, Inc.
  • Essity AB
  • GlaxoSmithKline PLC
  • Healthium Medtech Limited
  • Integra LifeSciences Corporation
  • Medline Industries, Inc.
  • MIMEDX, Inc.
  • Molnlycke Health Care AB
  • Organogenesis, Inc.
  • PAUL HARTMANN AG
  • Pristyn Care
  • Reapplix A/S
  • SANUWAVE Health, Inc.
  • SIGVARIS Group
  • Smith & Nephew PLC
  • SynerHeal Pharmaceuticals
  • Tissue Regenix Ltd.
  • URGO Medical, Australia Pty Ltd.
Product Code: MRR-F927BA462A59

The Diabetic Foot Ulcer Treatment Market was valued at USD 5.35 billion in 2023, expected to reach USD 5.69 billion in 2024, and is projected to grow at a CAGR of 6.56%, to USD 8.35 billion by 2030.

The diabetic foot ulcer treatment market encompasses a broad range of products and services aimed at managing and healing foot ulcers in diabetic patients. This includes both advanced wound care solutions such as dressings, grafts, and negative pressure wound therapy, as well as pharmaceuticals like protease inhibitors and antibiotic treatments. The necessity for these treatments arises from the increasing global prevalence of diabetes, which heightens the risk of foot ulcers due to poor circulation and neuropathy, leading to the potential for severe infections and amputations if untreated. Applications span from hospital and in-clinic environments to home healthcare settings, with end-use primarily involving healthcare institutions and individual patients. Key factors influencing growth include advancements in wound care technologies, rising awareness among patients regarding the severity of diabetic complications, and government initiatives to improve diabetic care. On the opportunity front, the market offers potential in personalized medicine approaches and the integration of AI and IoT for remote monitoring and management of ulcers. Recommendations include investing in R&D for biodegradable and bioengineered wound care products and exploring partnerships for technology integration. However, market growth faces challenges such as high treatment costs, particularly in low-income regions, and the lack of skilled healthcare professionals. Regulatory barriers and reimbursement issues further complicate market dynamics. Innovation opportunities lie in telemedicine platforms for better patient compliance and developing cost-effective solutions to expand access in developing countries. The market is competitively fragmented yet collaborative, characterized by constant technological advancements and strategic alliances among key players to leverage shared expertise. Focus on patient-centric solutions that balance effectiveness with affordability can drive sustained growth, particularly if supported by policy frameworks that encourage innovation and reduce barriers to market entry.

KEY MARKET STATISTICS
Base Year [2023] USD 5.35 billion
Estimated Year [2024] USD 5.69 billion
Forecast Year [2030] USD 8.35 billion
CAGR (%) 6.56%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Diabetic Foot Ulcer Treatment Market

The Diabetic Foot Ulcer Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of diabetic foot ulcers among the geriatric population
    • Rising awareness about effective DPU management among healthcare professionals
  • Market Restraints
    • High cost of advanced wound care devices and therapies
  • Market Opportunities
    • Ongoing introduction of new active diabetic foot ulcer therapies
    • Growing development of cost-effective solutions for diabetic foot ulcer prevention
  • Market Challenges
    • Limited availability of reimbursement policies for diabetic foot ulcers

Porter's Five Forces: A Strategic Tool for Navigating the Diabetic Foot Ulcer Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Diabetic Foot Ulcer Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Diabetic Foot Ulcer Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Diabetic Foot Ulcer Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Diabetic Foot Ulcer Treatment Market

A detailed market share analysis in the Diabetic Foot Ulcer Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Diabetic Foot Ulcer Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Diabetic Foot Ulcer Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Diabetic Foot Ulcer Treatment Market

A strategic analysis of the Diabetic Foot Ulcer Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Diabetic Foot Ulcer Treatment Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Adocia SA, Alkem Laboratories Ltd., B. Braun SE, Cardinal Health, Inc., Centaur Pharmaceuticals Private Limited, Cipla Limited, Coloplast Corp., ConvaTec, Inc., Essity AB, GlaxoSmithKline PLC, Healthium Medtech Limited, Integra LifeSciences Corporation, Medline Industries, Inc., MIMEDX, Inc., Molnlycke Health Care AB, Organogenesis, Inc., PAUL HARTMANN AG, Pristyn Care, Reapplix A/S, SANUWAVE Health, Inc., SIGVARIS Group, Smith & Nephew PLC, SynerHeal Pharmaceuticals, Tissue Regenix Ltd., and URGO Medical, Australia Pty Ltd..

Market Segmentation & Coverage

This research report categorizes the Diabetic Foot Ulcer Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment, market is studied across Antibiotic Medications, Biologics, Therapy Devices, and Wound Care Dressings. The Biologics is further studied across Growth Factors and Skin Grafts. The Therapy Devices is further studied across Negative Pressure Wound Therapy and Ultrasound Therapy. The Wound Care Dressings is further studied across Alginate Dressings, Film Dressing, Foam Dressings, Hydrocolloid Dressings, Hydrofiber Dressings, Hydrogel Dressings, and Surgical Dressings.
  • Based on Ulcer Type, market is studied across Ischemic Ulcers, Neuro-Ischemic Ulcers, and Neuropathic Ulcers.
  • Based on End-use, market is studied across Ambulatory Imaging Center and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of diabetic foot ulcers among the geriatric population
      • 5.1.1.2. Rising awareness about effective DPU management among healthcare professionals
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced wound care devices and therapies
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing introduction of new active diabetic foot ulcer therapies
      • 5.1.3.2. Growing development of cost-effective solutions for diabetic foot ulcer prevention
    • 5.1.4. Challenges
      • 5.1.4.1. Limited availability of reimbursement policies for diabetic foot ulcers
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Treatment: Innovations in wound care dressings and therapy devices to optimize care and improve patient outcomes
    • 5.2.2. End-Use: Expanding availability of low-cost and advanced DFU treatments across hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Diabetic Foot Ulcer Treatment Market, by Treatment

  • 6.1. Introduction
  • 6.2. Antibiotic Medications
  • 6.3. Biologics
    • 6.3.1. Growth Factors
    • 6.3.2. Skin Grafts
  • 6.4. Therapy Devices
    • 6.4.1. Negative Pressure Wound Therapy
    • 6.4.2. Ultrasound Therapy
  • 6.5. Wound Care Dressings
    • 6.5.1. Alginate Dressings
    • 6.5.2. Film Dressing
    • 6.5.3. Foam Dressings
    • 6.5.4. Hydrocolloid Dressings
    • 6.5.5. Hydrofiber Dressings
    • 6.5.6. Hydrogel Dressings
    • 6.5.7. Surgical Dressings

7. Diabetic Foot Ulcer Treatment Market, by Ulcer Type

  • 7.1. Introduction
  • 7.2. Ischemic Ulcers
  • 7.3. Neuro-Ischemic Ulcers
  • 7.4. Neuropathic Ulcers

8. Diabetic Foot Ulcer Treatment Market, by End-use

  • 8.1. Introduction
  • 8.2. Ambulatory Imaging Center
  • 8.3. Hospital

9. Americas Diabetic Foot Ulcer Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Diabetic Foot Ulcer Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Diabetic Foot Ulcer Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Researchers develop 3D printed bandage that delivers innovative treatment for diabetic foot ulcers
    • 12.3.2. Healthium launches Theruptor Novo for diabetic foot ulcers
    • 12.3.3. Smith+Nephew announces new study showing GRAFIX Membrane cut the rate of diabetic foot ulcer recurrence in half compared to competitors
    • 12.3.4. Alkem Laboratories Announces Launch of Technology For Diabetic Foot Ulcer Management
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Adocia SA
  • 3. Alkem Laboratories Ltd.
  • 4. B. Braun SE
  • 5. Cardinal Health, Inc.
  • 6. Centaur Pharmaceuticals Private Limited
  • 7. Cipla Limited
  • 8. Coloplast Corp.
  • 9. ConvaTec, Inc.
  • 10. Essity AB
  • 11. GlaxoSmithKline PLC
  • 12. Healthium Medtech Limited
  • 13. Integra LifeSciences Corporation
  • 14. Medline Industries, Inc.
  • 15. MIMEDX, Inc.
  • 16. Molnlycke Health Care AB
  • 17. Organogenesis, Inc.
  • 18. PAUL HARTMANN AG
  • 19. Pristyn Care
  • 20. Reapplix A/S
  • 21. SANUWAVE Health, Inc.
  • 22. SIGVARIS Group
  • 23. Smith & Nephew PLC
  • 24. SynerHeal Pharmaceuticals
  • 25. Tissue Regenix Ltd.
  • 26. URGO Medical, Australia Pty Ltd.

LIST OF FIGURES

  • FIGURE 1. DIABETIC FOOT ULCER TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. DIABETIC FOOT ULCER TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DIABETIC FOOT ULCER TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DIABETIC FOOT ULCER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIABETIC FOOT ULCER TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIABETIC FOOT ULCER TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ANTIBIOTIC MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY SKIN GRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY NEGATIVE PRESSURE WOUND THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULTRASOUND THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ALGINATE DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY FILM DRESSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY FOAM DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY HYDROCOLLOID DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY HYDROFIBER DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY HYDROGEL DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY SURGICAL DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ISCHEMIC ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY NEURO-ISCHEMIC ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY NEUROPATHIC ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY AMBULATORY IMAGING CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY WOUND CARE DRESSINGS, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM DIABETIC FOOT ULCER TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 283. DIABETIC FOOT ULCER TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 284. DIABETIC FOOT ULCER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023